Author:
Chen C-Y,Lin L-I,Tang J-L,Tsay W,Chang H-H,Yeh Y-C,Huang C-F,Chiou R-J,Yao M,Ko B-S,Chen Y-C,Lin K-H,Lin D-T,Tien H-F
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference9 articles.
1. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365: 1054–1061.
2. Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 2003; 34: 148–150.
3. Padua RA, Guinn BA, Al-Sabah AI, Smith M, Taylor C, Pettersson T et al. RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a ten-year follow-up. Leukemia 1998; 12: 887–892.
4. Hugues L, Cave H, Philippe N, Pereira S, Fenaux P, Preudhomme C . Mutations of PTPN11 are rare in adult myeloid malignancies. Haematologica 2005; 90: 853–854.
5. Johan MF, Bowen DT, Frew ME, Goodeve AC, Wilson GA, Peake IR et al. Mutations in PTPN11 are uncommon in adult myelodysplastic syndromes and acute myeloid leukaemia. Br J Haematol 2004; 124: 843–844.
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献